Infantile hemangiomas: a look back and future directions

Area of Science:

• Pediatric vascular anomalies
• Developmental biology
• Oncology

Background:

• Infantile hemangiomas (IH) are common benign vascular tumors in infants.
• Recent research has significantly deepened the understanding of IH biology and natural history.
• Key molecular pathways and genetic factors are increasingly implicated in IH development.

Purpose of the Study:

• To summarize major advancements in infantile hemangioma research over the past 10 years.
• To highlight key discoveries in IH pathogenesis, natural history, and therapeutic strategies.
• To provide an overview of the current state of knowledge regarding infantile hemangiomas.

Main Methods:

• Review of recent scientific literature and prospective studies on infantile hemangiomas.
• Analysis of findings from new research models, including genetic and molecular investigations.
• Synthesis of data on natural history, complications, and treatment outcomes.

Main Results:

• Development of the first mouse model for infantile hemangioma growth.
• Identification of key genes, such as vascular Endothelial Growth Factor Receptor (VEGFR), involved in IH proliferation.
• Accumulation of substantial data on IH natural history, associated complications, and structural impacts from large prospective studies.
• Emergence of highly effective new therapeutic options for infantile hemangiomas.

Conclusions:

• The last decade has yielded transformative insights into infantile hemangioma biology and management.
• Advances in research have paved the way for more targeted and effective therapeutic interventions.
• Continued investigation promises further improvements in the care and outcomes for infants with hemangiomas.